MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen.
Department of Pediatric Hematology and Oncology, University of Hamburg, Germany.
U
U
zur Stadt
D O
DO
Harms
S
S
Schlüter
M
M
Schrappe
U
U
Goebel
H
H
Spaar
G
G
Janka
H
H
Kabisch
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D016130:Immunophenotyping; D018365:Neoplasm, Residual; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D011379:Prognosis; D016896:Treatment Outcome